Supernus Pharmaceuticals (SUPN)
(Real Time Quote from BATS)
$28.89 USD
+0.27 (0.94%)
Updated Jul 15, 2024 01:18 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Bottom 32% (171 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.42 | 9.99 |
Current Quarter Estimate | 0.37 | 1.25 | 61.00 |
Year Ago Quarter Estimate | -0.02 | -4.28 | 54.84 |
Next Quarter Estimate | 0.39 | 1.37 | 63.00 |
Next Year Estimate | 2.10 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8,650.00 | 12.40 | 15.67 |
Next Year | 20.00 | 15.20 | 9.31 |
Last 5 Years | -61.60 | 0.10 | 8.10 |
Next 5 Years | NA | 14.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 1.64 |
Price/Book (MRQ) | 1.69 | 1.31 |
Price/Cash Flow (MRFY) | 18.06 | 10.20 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -2.60% | NA |
Return on Equity (TTM) | -1.68% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.